ArticleTargeted oncology2018
Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines.
Valentina Restelli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleTargeted oncology2018
Valentina Restelli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.